Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2016

01-07-2016 | Original Article

A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results

Authors: Ben Boursi, Ronac Mamtani, Wei-Ting Hwang, Kevin Haynes, Yu-Xiao Yang

Published in: Digestive Diseases and Sciences | Issue 7/2016

Login to get access

Abstract

Background

Current risk scores for colorectal cancer (CRC) are based on demographic and behavioral factors and have limited predictive values.

Aim

To develop a novel risk prediction model for sporadic CRC using clinical and laboratory data in electronic medical records.

Methods

We conducted a nested case–control study in a UK primary care database. Cases included those with a diagnostic code of CRC, aged 50–85. Each case was matched with four controls using incidence density sampling. CRC predictors were examined using univariate conditional logistic regression. Variables with p value <0.25 in the univariate analysis were further evaluated in multivariate models using backward elimination. Discrimination was assessed using receiver operating curve. Calibration was evaluated using the McFadden’s R2. Net reclassification index (NRI) associated with incorporation of laboratory results was calculated. Results were internally validated.

Results

A model similar to existing CRC prediction models which included age, sex, height, obesity, ever smoking, alcohol dependence, and previous screening colonoscopy had an AUC of 0.58 (0.57–0.59) with poor goodness of fit. A laboratory-based model including hematocrit, MCV, lymphocytes, and neutrophil–lymphocyte ratio (NLR) had an AUC of 0.76 (0.76–0.77) and a McFadden’s R2 of 0.21 with a NRI of 47.6 %. A combined model including sex, hemoglobin, MCV, white blood cells, platelets, NLR, and oral hypoglycemic use had an AUC of 0.80 (0.79–0.81) with a McFadden’s R2 of 0.27 and a NRI of 60.7 %. Similar results were shown in an internal validation set.

Conclusion

A laboratory-based risk model had good predictive power for sporadic CRC risk.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.CrossRefPubMed
2.
go back to reference American Cancer Society. Colorectal Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015. American Cancer Society. Colorectal Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015.
5.
go back to reference Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancer. N Engl J Med. 1988;319:533–537.CrossRefPubMed Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancer. N Engl J Med. 1988;319:533–537.CrossRefPubMed
6.
go back to reference Levin B, Lieberman D, McFarland B, et al. Screening and surveillance for the early detection of CRC and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-society Task Force on CRC, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed Levin B, Lieberman D, McFarland B, et al. Screening and surveillance for the early detection of CRC and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-society Task Force on CRC, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed
7.
go back to reference Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–521.CrossRefPubMed Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–521.CrossRefPubMed
8.
go back to reference Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011;106:1911–1921.CrossRefPubMedPubMedCentral Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011;106:1911–1921.CrossRefPubMedPubMedCentral
9.
go back to reference Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159:77–85.CrossRefPubMedPubMedCentral Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med. 2013;159:77–85.CrossRefPubMedPubMedCentral
10.
go back to reference Winawer SJ, Zauber AG, Ho MN, et al. The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1983.CrossRefPubMed Winawer SJ, Zauber AG, Ho MN, et al. The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1983.CrossRefPubMed
11.
go back to reference Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.CrossRefPubMedPubMedCentral Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.CrossRefPubMedPubMedCentral
12.
go back to reference Laiyemo AO, Pinsky PF, Marcus PM, et al. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7:562–567.CrossRefPubMed Laiyemo AO, Pinsky PF, Marcus PM, et al. Utilization and yield of surveillance colonoscopy in the continued follow-up study of the polyp prevention trial. Clin Gastroenterol Hepatol. 2009;7:562–567.CrossRefPubMed
13.
go back to reference Sint NJ, de Jonge V, van Baalen O, et al. Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates. Endoscopy. 2013;45:545–552.CrossRef Sint NJ, de Jonge V, van Baalen O, et al. Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates. Endoscopy. 2013;45:545–552.CrossRef
14.
go back to reference Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886.CrossRefPubMed Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–1886.CrossRefPubMed
15.
go back to reference Optenberg SA, Clark JY, Brawer MK, Thompson IM, Stein CR, Friedrichs P. Development of a decision-making tool to predict risk of prostate cancer: the cancer of the prostate risk index (CAPRI) test. Urology. 1997;50:665–672.CrossRefPubMed Optenberg SA, Clark JY, Brawer MK, Thompson IM, Stein CR, Friedrichs P. Development of a decision-making tool to predict risk of prostate cancer: the cancer of the prostate risk index (CAPRI) test. Urology. 1997;50:665–672.CrossRefPubMed
16.
go back to reference Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000;11:477–488.CrossRefPubMed Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control. 2000;11:477–488.CrossRefPubMed
17.
go back to reference Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–263.CrossRefPubMed Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–263.CrossRefPubMed
18.
go back to reference Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–1119.CrossRefPubMedPubMedCentral Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–1119.CrossRefPubMedPubMedCentral
19.
go back to reference Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–1241.CrossRefPubMed Yeoh KG, Ho KY, Chiu HM, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–1241.CrossRefPubMed
20.
go back to reference Wong MC, Lam TY, Tsoi KK, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63:1130–1136.CrossRefPubMed Wong MC, Lam TY, Tsoi KK, et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut. 2014;63:1130–1136.CrossRefPubMed
21.
go back to reference Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–693.CrossRefPubMed Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–693.CrossRefPubMed
22.
go back to reference Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–698.CrossRefPubMed Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–698.CrossRefPubMed
23.
go back to reference Lubin JH, Gail MH. Biased selection of controls for case–control analysis of cohort studies. Biometrics. 1984;40:63–75.CrossRefPubMed Lubin JH, Gail MH. Biased selection of controls for case–control analysis of cohort studies. Biometrics. 1984;40:63–75.CrossRefPubMed
24.
go back to reference Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18:76–83.CrossRefPubMed Maguire A, Blak BT, Thompson M. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf. 2009;18:76–83.CrossRefPubMed
25.
go back to reference Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12:171–177.PubMed Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care. 2004;12:171–177.PubMed
26.
go back to reference Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16:393–401.CrossRefPubMed Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16:393–401.CrossRefPubMed
27.
go back to reference Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19:251–255.PubMed Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19:251–255.PubMed
28.
go back to reference Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in the health improvement network. Pharmacoepidemiol Drug Saf. 2009;18:730–736.CrossRefPubMed Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD. Cancer incidence in the health improvement network. Pharmacoepidemiol Drug Saf. 2009;18:730–736.CrossRefPubMed
29.
go back to reference Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf. 2005;14:443–451.CrossRefPubMed Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the general practice research database. Pharmacoepidemiol Drug Saf. 2005;14:443–451.CrossRefPubMed
30.
go back to reference Maringe C, Walters S, Rachet B, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013;52:919–932.CrossRefPubMed Maringe C, Walters S, Rachet B, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013;52:919–932.CrossRefPubMed
31.
go back to reference Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137.PubMed Mickey J, Greenland S. A study of the impact of confounder-selection criteria on effect estimation. Am J Epidemiol. 1989;129:125–137.PubMed
32.
go back to reference Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512–5528.CrossRefPubMed Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26:5512–5528.CrossRefPubMed
33.
go back to reference Binder H, Sauerbrei W, Royston P. Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response. Stat Med. 2013;32:2262–2277.CrossRefPubMed Binder H, Sauerbrei W, Royston P. Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response. Stat Med. 2013;32:2262–2277.CrossRefPubMed
34.
go back to reference McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, ed. Frontiers in Econometrics. New York: Academic Press; 1974:105–142. McFadden D. Conditional logit analysis of qualitative choice behavior. In: Zarembka P, ed. Frontiers in Econometrics. New York: Academic Press; 1974:105–142.
35.
go back to reference Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.CrossRefPubMed Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.CrossRefPubMed
36.
go back to reference Spell DW, Jones DV Jr, Harper WF, Bessman D. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37–42.CrossRefPubMed Spell DW, Jones DV Jr, Harper WF, Bessman D. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37–42.CrossRefPubMed
37.
go back to reference Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The importance of anemia in diagnosing colorectal cancer: a case–control study using electronic primary care records. Br J Cancer. 2008;98:323–327.CrossRefPubMedPubMedCentral Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The importance of anemia in diagnosing colorectal cancer: a case–control study using electronic primary care records. Br J Cancer. 2008;98:323–327.CrossRefPubMedPubMedCentral
38.
go back to reference Tchebiner JZ, Nutman A, Boursi B, et al. Diagnostic and prognostic value of thrombocytosis in admitted medical patients. Am J Med Sci. 2011;342:395–401.CrossRefPubMed Tchebiner JZ, Nutman A, Boursi B, et al. Diagnostic and prognostic value of thrombocytosis in admitted medical patients. Am J Med Sci. 2011;342:395–401.CrossRefPubMed
39.
go back to reference Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19:342–344.CrossRefPubMed Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19:342–344.CrossRefPubMed
40.
go back to reference Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12:1624–1634.CrossRefPubMed Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12:1624–1634.CrossRefPubMed
41.
go back to reference Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011;106:1099–1106.CrossRefPubMed Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011;106:1099–1106.CrossRefPubMed
43.
go back to reference Pencina MJ, Steyerberg EW, D’Agostino RB. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.CrossRefPubMed Pencina MJ, Steyerberg EW, D’Agostino RB. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11–21.CrossRefPubMed
44.
go back to reference Pankratz VS, Degnim AC, Frank RD, et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33:923–929.CrossRefPubMedPubMedCentral Pankratz VS, Degnim AC, Frank RD, et al. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015;33:923–929.CrossRefPubMedPubMedCentral
Metadata
Title
A Risk Prediction Model for Sporadic CRC Based on Routine Lab Results
Authors
Ben Boursi
Ronac Mamtani
Wei-Ting Hwang
Kevin Haynes
Yu-Xiao Yang
Publication date
01-07-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4081-x

Other articles of this Issue 7/2016

Digestive Diseases and Sciences 7/2016 Go to the issue